|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Loss | |||||
| OPERATING ACTIVITIES | |||||
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash: | |||||
| Amortization of property and equipment | |||||
| Amortization of intangible assets | |||||
| Impairment of goodwill and other intangibles | |||||
| Finance expense | |||||
| Accretion of interest expense | |||||
| Loss on sale of equipment | |||||
| Effect of foreign exchange | |||||
| Gain from debt settlement | |||||
| Share-based compensation | |||||
| Deposits | |||||
| Receivables | |||||
| Prepaid expenses and other current assets | |||||
| Deferred revenue | |||||
| Accounts payable and accrued liabilities | |||||
| Cash flows used in operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Proceeds from sale of equipment | |||||
| Development of intangible assets | |||||
| Cash flows used in investing activities | |||||
| Change in cash during the period | |||||
| FINANCING ACTIVITIES | |||||
| Repayment of notes payable - related party | |||||
| Repayment of notes payable – related party | |||||
| Proceeds from convertible debt – related party | |||||
| Proceeds from warrant exercises | |||||
| Proceeds from share issuances | |||||
| Payments for lease liabilities | |||||
| Payments of share and debt issuance costs | |||||
| Cash flows from financing activities | |||||
| Effect of foreign exchange | |||||
| Change in cash and cash equivalents during the period | |||||
| Cash and cash equivalents - Beginning of period | |||||
| Cash and cash equivalents - End of period | |||||
| Noncash investing and financing activities | |||||
| Debt converted into common stock and warrants | |||||
Loading...